Skip to main content
Caplight Logo









Vertigenius

Vertigenius

Private
DublinHealthcare & Life Scienceshttps://vertigenius.com/

Last Round

VC Round

Apr 8, 2026

Total Funding Raised

$2.26M

Company Overview

Vertigenius is a digital health company that provides a vestibular rehabilitation platform consisting of a clinician portal, patient mobile application, and wearable head sensor to treat dizziness and balance disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement, Telemedicine, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

vestibular rehabilitationremote therapeutic monitoringRTMdigital therapeuticsDTxremote patient monitoringRPMwearable sensorinertial motion unitIMUbalance disorder treatmenttelemedicine platformphysical therapy softwaremedtechhealth IoTpatient engagement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vertigenius Comparables

Compare Vertigenius with similar companies based on industry and business-model similarity.

Vertigenius comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Linus Health
77%
GripAble
76%
BioVirtua
66%

Vertigenius Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 8, 2026
SeedMay 8, 2024

Key People

Founding team and executive leadership

Mark Barry

Chief Executive Officer, Board Chair

Executive Team

Damien Daly

Chief Technology Officer

Executive Team

Vertigenius Investors

Notable investors and investment history

Vertigenius investors
InvestorRounds
Atlantic Bridge CapitalVC Round, Seed
AscentifiVC Round, Seed
Xcendra VenturesVC Round
Irrus InvestmentsVC Round
The MedTech SyndicateVC Round
Enterprise IrelandVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 5, 2026

    Monthly visitors increased 204% MoM.

  • Mar 5, 2026

    Monthly visitors increased 836% MoM.

Vertigenius Filings

Explore SEC and related filing metadata, where available.

Vertigenius filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vertigenius's valuation, stock price, and market status.

Is Vertigenius a public or private company?

Vertigenius is a private company.

What is the current stock price of Vertigenius?

Vertigenius is a private company with no public stock price. No recent secondary market data is available.

How much is Vertigenius worth (valuation)?

Valuation information for Vertigenius is not publicly available.

Can I buy Vertigenius stock?

Vertigenius shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vertigenius's last funding round?

Vertigenius's most recent funding round was VC Round on April 8, 2026.

Who are the main investors in Vertigenius?

Key investors in Vertigenius include Atlantic Bridge Capital.

Will Vertigenius IPO soon?

No public IPO plans have been announced for Vertigenius.

How can I track Vertigenius secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vertigenius's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDublin
Employee Range13
Year FoundedN/A
Last FundingApr 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?